Orbem raises €55.5M Series B to scale AI-powered MRI technology

January 20, 2026 at 09:30 AM UTC
Tech.eu
Original: EN
Orbem raises €55.5M Series B to scale AI-powered MRI technology

Munich-based deeptech firm Orbem has secured €55.5 million in a Series B funding round, led by Innovation Industries. The company leverages artificial intelligence and magnetic resonance imaging (MRI) to analyze biological materials. This financing will support Orbem's expansion into the United States and the development of new applications. Orbem's technology applies AI to industrialize MRI, enabling fast, scalable, and non-invasive analysis. Their solutions provide actionable insights across agriculture, food production, and health, generating data to support decision-making. Their flagship product, Genus Focus, uses AI-enabled MRI to determine the sex of poultry eggs in under one second, with over 170 million eggs scanned to date. The technology impacts the poultry industry by improving efficiency, reducing waste, and increasing transparency. Orbem is also expanding into the fruit and vegetable sector, offering non-destructive quality analysis. The company aims to address inefficiencies within biological value chains, offering a sustainable alternative to current practices and promoting European digital sovereignty. Orbems's Series B funding also involves Supernova Invest and investments from General Catalyst, 83North, among others. Orbem will continue developing healthcare applications based on large-scale biological data.

Curated and translated by Europe Digital for our multilingual European audience.

Source Information

Publication: Tech.eu
Published: January 20, 2026 at 09:30 AM UTC
All rights remain with the original publisher.